Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D de Zeeuw

Showing results (1-10 of 223) with videos related to

Pageof 23
Sort By:
Journal of Human Hypertension|October 1, 1996
Titrating for antiproteinuric effect: the clue to renoprotection?G Navis, D de Zeeuw
Diabetes, Obesity & Metabolism|September 23, 2014
The paradox created by commenting on large clinical trial resultsD de Zeeuw, C Meyer
Clinical Science (London, England : 1979)|April 1, 1985
Haemodynamics of renal artery stenosis (a comment based on Ohm's law)R M Huisman, D de Zeeuw
Current Opinion in Nephrology and Hypertension|February 2, 2000
The antihypertensive and renal effects of angiotensin II receptor antagonists: remaining questionsR T Gansevoort, D de Zeeuw
Nederlands Tijdschrift Voor Geneeskunde|March 15, 1997
[The floating kidney]J C Roos, D de Zeeuw
Contributions to Nephrology|January 1, 1978
Unilateral kidney blood flow measurement using the 81Rb/81mKr ratioG van Herk, D de Zeeuw
Journal of Human Hypertension|October 23, 1997
Pharmacokinetics of candesartan cilexetil in patients with renal or hepatic impairmentD de Zeeuw, G Remuzzi, W Kirch
Deutsche Medizinische Wochenschrift (1946)|May 10, 1991
[Renal effects of angiotensin-converting enzyme inhibitors: from the feared side effect to the desired treatment goal]P E de Jong, D de Zeeuw
Nephron. Clinical Practice|June 3, 2010
Dual RAS therapy not on target, but fully aliveH J Lambers Heerspink, D de Zeeuw
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Erythrocyte sodium-potassium co-transport in hypertensionD de Zeeuw, J F Jilderda, T Tepper
Pageof 23

Showing results (1-10 of 223) with videos related to

Sort By:
Pageof 23
Journal of Human Hypertension|October 1, 1996
Titrating for antiproteinuric effect: the clue to renoprotection?G Navis, D de Zeeuw
Diabetes, Obesity & Metabolism|September 23, 2014
The paradox created by commenting on large clinical trial resultsD de Zeeuw, C Meyer
Clinical Science (London, England : 1979)|April 1, 1985
Haemodynamics of renal artery stenosis (a comment based on Ohm's law)R M Huisman, D de Zeeuw
Current Opinion in Nephrology and Hypertension|February 2, 2000
The antihypertensive and renal effects of angiotensin II receptor antagonists: remaining questionsR T Gansevoort, D de Zeeuw
Nederlands Tijdschrift Voor Geneeskunde|March 15, 1997
[The floating kidney]J C Roos, D de Zeeuw
Contributions to Nephrology|January 1, 1978
Unilateral kidney blood flow measurement using the 81Rb/81mKr ratioG van Herk, D de Zeeuw
Journal of Human Hypertension|October 23, 1997
Pharmacokinetics of candesartan cilexetil in patients with renal or hepatic impairmentD de Zeeuw, G Remuzzi, W Kirch
Deutsche Medizinische Wochenschrift (1946)|May 10, 1991
[Renal effects of angiotensin-converting enzyme inhibitors: from the feared side effect to the desired treatment goal]P E de Jong, D de Zeeuw
Nephron. Clinical Practice|June 3, 2010
Dual RAS therapy not on target, but fully aliveH J Lambers Heerspink, D de Zeeuw
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Erythrocyte sodium-potassium co-transport in hypertensionD de Zeeuw, J F Jilderda, T Tepper
Pageof 23